Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC). This is an ASCO Meeting Abstract from the 2011 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback